SCHEMBL8352106

SCHEMBL8352106

O=C(NCc1cccc(Cl)c1Cl)c1cccc(-c2ccnc(Nc3ccccc3)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ LMNA P02545 2/20 0.52
▸ MAPT P10636 1/20 0.52
▸ MAPK8 P45983 5/20 0.49
▸ MAPK10 P53779 5/20 0.49
▸ JAK2 O60674 1/20 0.49
▸ TYK2 P29597 1/20 0.49
▸ ROCK2 O75116 4/20 0.47
▸ PRKCA P17252 2/20 0.47
▸ GRK2 P25098 2/20 0.47
▸ PIP5K1C O60331 3/20 0.45
▸ PIK3CA P42336 3/20 0.45
▸ MAPK14 Q16539 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ CASP6 P55212 1/20 0.44
▸ ROCK1 Q13464 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8350912 0.85 CSNK1D (0.53) MAPTMAPK8MAPK10JAK2ROCK1
SCHEMBL8351616 0.84 ABL1 (0.52) SMN1; SMN2LMNAMAPTMAPK8MAPK10
SCHEMBL8352104 0.84 CFD (0.59) SMN1; SMN2LMNAMAPK8MAPK10JAK2
SCHEMBL8349000 0.81 MAPK10 (0.48) LMNAMAPK8MAPK10JAK2ROCK2
SCHEMBL8351088 0.80 ALDH1A1 (0.62) SMN1; SMN2MAPTMAPK8MAPK10TP53
SCHEMBL8351021 0.79 HPGD (0.56) SMN1; SMN2LMNAMAPTMAPK8MAPK10
SCHEMBL1518585 0.78 CNR1 (0.55) SMN1; SMN2LMNAMAPTMAPK8MAPK10
SCHEMBL8352200 0.75 MEN1 (0.60) MAPK8MAPK10ROCK2PIP5K1CPIK3CA
SCHEMBL14254327 0.74 MAPK8 (0.59) MAPTMAPK8MAPK10PIP5K1CPIK3CA
SCHEMBL8351466 0.74 ROCK2 (0.64) LMNAMAPK8MAPK10ROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
WO-2004041789-A1 COMPOSITIONS USEFUL AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-05-21 — — WO disclosed
Send feedback